Ad
Tuesday, 14 March 2017
India's Sun Pharma says FDA to lift ban on Mohali drug plant
MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday that U.S. regulators plan to lift a ban on its Mohali plant in northern India, allowing the company to restart supplies from there after four years.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment